Dr Shunda Lynette Garner, MD | |
8613 Ms Highway 12, Ackerman, MS 39735-8917 | |
(662) 285-4400 | |
Not Available |
Full Name | Dr Shunda Lynette Garner |
---|---|
Gender | Female |
Speciality | Emergency Medicine |
Experience | 27 Years |
Location | 8613 Ms Highway 12, Ackerman, Mississippi |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124017546 | NPI | - | NPPES |
00122194 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 16790 (Mississippi) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Choctaw Regional Medical Center | Ackerman, MS | Hospital |
Webster General Hospital/ Swing Bed | Eupora, MS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Choctaw Regional Medical Center | 2567682206 | 26 |
Webster Health Services Inc | 6901892421 | 19 |
News Archive
egg health innovations (previously part of Virgo Health) has launched a new wearable technology product which provides a fully immersive, first person patient insight experience. Named "Virtual Mile" it allows someone to authentically understand another person by experiencing the world from a virtual first person vantage point, conceived from a need to capture greater insights in sensitive conditions and rare diseases.
Responding to a recent study showing that 40% of patients who receive CRT-ICD therapy do not benefit from the device (Sipahi, et al – 6/13/11), Wojciech Zareba, MD, PhD, stated that improving risk stratification of heart failure patients eligible for an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy with a defibrillator (CRT-D) is essential.
Harvard Stem Cell Institute researchers at Harvard University and the Broad Institute of Harvard and MIT have found evidence that bone marrow transplantation may one day be beneficial to a subset of patients suffering from amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder more commonly known as Lou Gehrig's disease.
Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it is adding development and manufacturing softgel capability in its Cincinnati facility, providing the pharmaceutical industry a new contract provider for this popular drug delivery system.
› Verified 3 days ago
Entity Name | Webster Health Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1982719621 PECOS PAC ID: 6901892421 Enrollment ID: O20040421001047 |
News Archive
egg health innovations (previously part of Virgo Health) has launched a new wearable technology product which provides a fully immersive, first person patient insight experience. Named "Virtual Mile" it allows someone to authentically understand another person by experiencing the world from a virtual first person vantage point, conceived from a need to capture greater insights in sensitive conditions and rare diseases.
Responding to a recent study showing that 40% of patients who receive CRT-ICD therapy do not benefit from the device (Sipahi, et al – 6/13/11), Wojciech Zareba, MD, PhD, stated that improving risk stratification of heart failure patients eligible for an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy with a defibrillator (CRT-D) is essential.
Harvard Stem Cell Institute researchers at Harvard University and the Broad Institute of Harvard and MIT have found evidence that bone marrow transplantation may one day be beneficial to a subset of patients suffering from amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder more commonly known as Lou Gehrig's disease.
Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it is adding development and manufacturing softgel capability in its Cincinnati facility, providing the pharmaceutical industry a new contract provider for this popular drug delivery system.
› Verified 3 days ago
Entity Name | Pontotoc Health Services, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821103516 PECOS PAC ID: 6002895356 Enrollment ID: O20040719001336 |
News Archive
egg health innovations (previously part of Virgo Health) has launched a new wearable technology product which provides a fully immersive, first person patient insight experience. Named "Virtual Mile" it allows someone to authentically understand another person by experiencing the world from a virtual first person vantage point, conceived from a need to capture greater insights in sensitive conditions and rare diseases.
Responding to a recent study showing that 40% of patients who receive CRT-ICD therapy do not benefit from the device (Sipahi, et al – 6/13/11), Wojciech Zareba, MD, PhD, stated that improving risk stratification of heart failure patients eligible for an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy with a defibrillator (CRT-D) is essential.
Harvard Stem Cell Institute researchers at Harvard University and the Broad Institute of Harvard and MIT have found evidence that bone marrow transplantation may one day be beneficial to a subset of patients suffering from amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder more commonly known as Lou Gehrig's disease.
Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it is adding development and manufacturing softgel capability in its Cincinnati facility, providing the pharmaceutical industry a new contract provider for this popular drug delivery system.
› Verified 3 days ago
Entity Name | Correct Care, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215987441 PECOS PAC ID: 8628980992 Enrollment ID: O20131122000662 |
News Archive
egg health innovations (previously part of Virgo Health) has launched a new wearable technology product which provides a fully immersive, first person patient insight experience. Named "Virtual Mile" it allows someone to authentically understand another person by experiencing the world from a virtual first person vantage point, conceived from a need to capture greater insights in sensitive conditions and rare diseases.
Responding to a recent study showing that 40% of patients who receive CRT-ICD therapy do not benefit from the device (Sipahi, et al – 6/13/11), Wojciech Zareba, MD, PhD, stated that improving risk stratification of heart failure patients eligible for an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy with a defibrillator (CRT-D) is essential.
Harvard Stem Cell Institute researchers at Harvard University and the Broad Institute of Harvard and MIT have found evidence that bone marrow transplantation may one day be beneficial to a subset of patients suffering from amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder more commonly known as Lou Gehrig's disease.
Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it is adding development and manufacturing softgel capability in its Cincinnati facility, providing the pharmaceutical industry a new contract provider for this popular drug delivery system.
› Verified 3 days ago
Entity Name | Choctaw Regional Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235547878 PECOS PAC ID: 2567682206 Enrollment ID: O20141215002502 |
News Archive
egg health innovations (previously part of Virgo Health) has launched a new wearable technology product which provides a fully immersive, first person patient insight experience. Named "Virtual Mile" it allows someone to authentically understand another person by experiencing the world from a virtual first person vantage point, conceived from a need to capture greater insights in sensitive conditions and rare diseases.
Responding to a recent study showing that 40% of patients who receive CRT-ICD therapy do not benefit from the device (Sipahi, et al – 6/13/11), Wojciech Zareba, MD, PhD, stated that improving risk stratification of heart failure patients eligible for an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy with a defibrillator (CRT-D) is essential.
Harvard Stem Cell Institute researchers at Harvard University and the Broad Institute of Harvard and MIT have found evidence that bone marrow transplantation may one day be beneficial to a subset of patients suffering from amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder more commonly known as Lou Gehrig's disease.
Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it is adding development and manufacturing softgel capability in its Cincinnati facility, providing the pharmaceutical industry a new contract provider for this popular drug delivery system.
› Verified 3 days ago
Entity Name | Baptist Memorial Hospital-calhoun Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881142461 PECOS PAC ID: 5395024210 Enrollment ID: O20161203000022 |
News Archive
egg health innovations (previously part of Virgo Health) has launched a new wearable technology product which provides a fully immersive, first person patient insight experience. Named "Virtual Mile" it allows someone to authentically understand another person by experiencing the world from a virtual first person vantage point, conceived from a need to capture greater insights in sensitive conditions and rare diseases.
Responding to a recent study showing that 40% of patients who receive CRT-ICD therapy do not benefit from the device (Sipahi, et al – 6/13/11), Wojciech Zareba, MD, PhD, stated that improving risk stratification of heart failure patients eligible for an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy with a defibrillator (CRT-D) is essential.
Harvard Stem Cell Institute researchers at Harvard University and the Broad Institute of Harvard and MIT have found evidence that bone marrow transplantation may one day be beneficial to a subset of patients suffering from amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder more commonly known as Lou Gehrig's disease.
Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it is adding development and manufacturing softgel capability in its Cincinnati facility, providing the pharmaceutical industry a new contract provider for this popular drug delivery system.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Shunda Lynette Garner, MD 278 Dinkens Rd, Pickens, MS 39146-9587 Ph: (601) 672-7274 | Dr Shunda Lynette Garner, MD 8613 Ms Highway 12, Ackerman, MS 39735-8917 Ph: (662) 285-4400 |
News Archive
egg health innovations (previously part of Virgo Health) has launched a new wearable technology product which provides a fully immersive, first person patient insight experience. Named "Virtual Mile" it allows someone to authentically understand another person by experiencing the world from a virtual first person vantage point, conceived from a need to capture greater insights in sensitive conditions and rare diseases.
Responding to a recent study showing that 40% of patients who receive CRT-ICD therapy do not benefit from the device (Sipahi, et al – 6/13/11), Wojciech Zareba, MD, PhD, stated that improving risk stratification of heart failure patients eligible for an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy with a defibrillator (CRT-D) is essential.
Harvard Stem Cell Institute researchers at Harvard University and the Broad Institute of Harvard and MIT have found evidence that bone marrow transplantation may one day be beneficial to a subset of patients suffering from amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder more commonly known as Lou Gehrig's disease.
Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it is adding development and manufacturing softgel capability in its Cincinnati facility, providing the pharmaceutical industry a new contract provider for this popular drug delivery system.
› Verified 3 days ago
Dr. Falan Nichole Mcknight, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8613 Ms Highway 12, Ackerman, MS 39735 Phone: 662-285-4400 | |
Mr. Harmon Sidney Prosser, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 64 N Louisville St, Ackerman, MS 39735 Phone: 662-285-9050 Fax: 662-285-9056 | |
Prentiss Parsons, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 356 W Cherry St, Ackerman, MS 39735 Phone: 662-285-3243 Fax: 662-285-3613 |